Hepatitis C virus infection complicating lupus nephritis

Nephrology Dialysis Transplantation

Volumn 11, Issue 7, 1996, Pages 1342-1345

  Albero, Ma D ^a   Rivera, F ^a,b   Merino, E ^a   Gil, Ma T ^a   Jimenez, L A ^a   Aranda, I ^a   Olivares, J ^a  

^a University General Hospital   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Hepatitis C virus; Lupus nephritis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030015361     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.7.1342     Document Type: Article

References (31)

1. Rostoker G, Deforges L, Ben Maadi et al Low prevalence of hepatitis C virus antibodies among adult patients with primary glomerulonephritis in France. Nephron 1993; 63: 367
2. Gonzalo A, Fernandez M, Navarro J, Ortuno J. Searching for hepatitis C virus in chronic primary glomerular diseases. Nephron 1995; 69: 96
3. Mac-Moune Lai F, Tam JSL, Liew CT, Ip M, Lai KN. Low prevalence of hepatitis C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong. Nephron 1995; 70: 367-368
4. Fabrizi F, Pozzi C, Farina M et al. Infezione da HCV in pazienti affetti da glomerulonefrite (GN) primitiva biopticamente accertata. Giornal Ital Nefrol 1995; 12 (SS): 13
5. Yamabe H, Johnson RJ. Gretch DR et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220-223
6. Johnson RJ, Gretch DM, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470
7. Doutrelepont JM, Adler M, Willems M, Durez P, Yap SH. Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 1993; 341: 317
8. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577
9. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G, Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991; 59: 319-320
10. Davada R, Peterson J, Weiner R, Croker B, Lau J. Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993; 22: 1288-1293
11. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495
12. Pucillo LP, Agnello V. Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from viruslike particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994; 3: 465-470
13. Johnson RJ, Willson R, Yamabe H et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994; 46: 1255-1263
14. D'Amico G. Is type II mixed cryoglobulinemia an essential part of hepatitis C virus (HCV)-associated glomerulonephritis? Nephrol Dial Transplant 1995; 10: 1279-1282
15. Stehman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ. Hepatitis C virus-associated glomerulonephritis. Curr Opin Nephrol Hypertens 1995; 4: 287-294
16. Misiani R, Vicari O, Bellavita P, Sonzogni A, Marin MG. Hepatitis C virus in renal tissue of patients with glomerulonephritis. Nephron 1994; 68: 400
17. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620
18. Garcia-Valdecasas J, Bernai C, Garcia F et al. Epidemiology of hepatitis C virus in patients with renal diseases. J Am Soc Nephrol 1994: 5:186-192
19. Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173
20. Gonzalo A, Navarro J, Barcena R, Quereda C, Ortuno J. IgA nephropathy associated with hepatitis C virus infection. Nephron 1995; 69: 354
21. Davis GL. Hepatitis B and C: influence of immunosuppression. Recent Results Cancer Res 1993; 132: 213-220
22. Boumpas DT, Austin III HA. Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992; 340: 741-745
23. Yoshiba M, Sekiyama K, Sugata F, Kanamori H, Kodama F, Okamoto H. Activation of hepatitis C virus following immunosuppressive treatment. Dig Dis Sci 1992; 37: 478
24. McHutchinson JG, Wilkes LB, Pockros PJ et al. Pulse corticosteroid therapy increased viremia (HCV RNA) in patients with chronic hepatitis C infection. Hepatology 1993; 18: 87A
25. Rao KV, Anderson WR, Kakiske BL, Dahl DC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241-250
26. Arend SM, Hagen EC, Kroes ACM. Bruijn JA, van der Woude J. Activation of chronic hepatitis C virus infection by cyclophosphamide in a patient with cANCA-positive vasculitis. Nephrol Dial Transplant 1995; 10: 884-887
27. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Meet 1994; 330:751-756
28. Johnson RJ, Gretch DR, Couser W et al. Hepatitis C virus-associated glomerulonephritis. Effect of β-interferon therapy. Kidney Int 1994; 46: 1700-1704
29. Lok ASF, Gerber MA. A young woman with chronic hepatitis. Hepatology 1993; 17: 739-745
30. Sanchez J, Castillo MJ, Garcia E, Ferrer JA. Lupus eritematoso sistemico inducido por tratamiento con interferon alfarrecombinante. Med Clin (Bare) 1994; 102: 198
31. Alberti A, Morsica G, Chemello L el al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HVC. Lancet 1992; 340: 697-698